Opendata, web and dolomites

LysoMod SIGNED

Genetic and Small Molecule Modifiers of Lysosomal Function

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LysoMod project word cloud

Explore the words cloud of the LysoMod project. It provides you a very rough idea of what is the project "LysoMod" about.

trials    drug    lsd    disorders    linked    biochemistry    companies    academic    generation    sectors    storage    mentored    genetics    cell    exchange    preparing    diagnostics    innovative    function    approved    life    age    exploring    pharmacology    optimize    personalized    proteomics    pathology    neurodegenerative    pioneer    cells    training    lysosomal    critical    rapid    people    ranging    expertise    careers    strategies    led    medicinal    clinical    private    therapeutic    public    area    medicine    transcriptomics    biomedical    disorder    chemistry    cross    quality    implementing    candidate    transfer    biology    modifier    expression    participant    multidisciplinary    either    lysosomes    young    mechanisms    gene    lysosome    collaborative    lysomod    prioritising    signalling    staff    therapies    play    health    action    mouse    lipidomics    human    dysfunction    biological    regulation    lsds    genes    variety    talk    innovate    drugs    diseases    complementary    rnas   

Project "LysoMod" data sheet

The following table provides information about the project.

Coordinator
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES 

Organization address
address: AVENIDA PROF EGAS MONIZ
city: LISBOA
postcode: 1649 028
website: www.imm.ul.pt

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website https://lysomod.wixsite.com/lysomod
 Total cost 1˙156˙500 €
 EC max contribution 1˙102˙500 € (95%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2016
 Funding Scheme MSCA-RISE
 Starting year 2017
 Duration (year-month-day) from 2017-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) coordinator 366˙300.00
2    GENOMED, DIAGNOSTICOS DE MEDICINA MOLECULAR SA PT (LISBOA) participant 240˙750.00
3    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 198˙000.00
4    INSTITUTUL DE BIOCHIMIE RO (BUCHAREST) participant 130˙500.00
5    CHRONOS BIOSYSTEMS SRL RO (Bucharest) participant 108˙000.00
6    INTRABIO LTD UK (LONDON) participant 27˙000.00
7    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) participant 18˙450.00
8    THE UNIVERSITY OF SUSSEX UK (BRIGHTON) participant 13˙500.00
9    FONDAZIONE TELETHON IT (ROMA) participant 0.00
10    LIPOTYPE DE (DRESDEN) participant 0.00
11    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE CL (SANTIAGO) partner 0.00
12    THE CHILDREN'S HOSPITAL OF PHILADELPHIA NON PROFIT ORG US (Philadelphia) partner 0.00
13    UNIVERSIDAD DE BUENOS AIRES AR (BUENOS AIRES) partner 0.00
14    UNIVERSIDAD DEL DESARROLLO CL (SAN CARLOS DE APOQUINDO) partner 0.00

Map

 Project objective

LysoMod will innovate in the area of personalized medicine for disorders linked to lysosomal dysfunction. This will be achieved by implementing a collaborative staff-exchange program between highly complementary and multidisciplinary academic and non-academic partners with expertise in pharmacology, medicinal chemistry, cell biology, biochemistry, mouse and human genetics, transcriptomics, proteomics and lipidomics. Based on the critical role that lysosomes play in cells, a better understanding of lysosomal function will have a major impact on human health, fostering the development of new strategies to improve quality of life for people affected by a variety of diseases, ranging from lysosomal storage diseases (LSDs) to age-related neurodegenerative disorders. LysoMod’s specific objectives are: 1) to develop and further optimize existing therapies for LSDs; 2) to identify new targets for personalized therapies for LSDs; and 3) to investigate the cross-talk between lysosomal function, signalling pathways and gene expression regulation. The pioneer work of a participant in the consortium led to the development of a drug that is approved for clinical use. LysoMod will i) investigate the mechanisms of action of this and other drugs in lysosome-related disorder; ii) identify modifier genes involved in LSD pathology and test their potential as new targets for personalized therapeutic approaches; iii) identify candidate RNAs that can be targeted to enhance lysosomal function. The companies in the consortium will ensure a rapid transfer of new knowledge into applications for diagnostics and clinical trials. Prioritising lysosomal dysfunction as a highly relevant biomedical problem, the LysoMod consortium will implement a mentored staff-exchange program to provide young researchers with high-level training in innovative approaches for exploring biological systems, preparing the next generation of researchers for careers either in the private or public health sectors.

 Deliverables

List of deliverables.
Organization of a summer school in Chile Other 2020-03-03 15:05:06
Project Website Internet-based social media Websites, patent fillings, videos etc. 2020-03-03 15:05:06

Take a look to the deliverables list in detail:  detailed list of LysoMod deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYSOMOD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LYSOMOD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

EXPLOR (2020)

EXperimentation and simulation based PLatform for beyond 5G Optical-wireless network Research and development

Read More  

SOMPATY (2020)

Spectral Optimization: From Mathematics to Physics and Advanced Technology

Read More  

RESEARCH (2018)

REmote SEnsing techniques for ARCHaeology

Read More